Pricing Log in Create free account

Compass Therapeutics, Inc. (CMPX) vs Cue Biopharma, Inc. (CUE)

Compass Therapeutics, Inc. and Cue Biopharma, Inc. are both Biotechnology companies. Compass Therapeutics, Inc. and Cue Biopharma, Inc. are of similar size ($136.7M and $136.1M). Compass Therapeutics, Inc. has the higher net margin (0.00% vs −435.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Compass Therapeutics, Inc. leads on 9 and Cue Biopharma, Inc. on 3.

Valuation

Metric CMPX CUE Biotechnology median
P/E n/m n/m 10.60
P/S n/m 3.15 9.40
P/B 0.86 51.41 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.40 n/m 0.66
EV/Sales n/m 2.74 9.02
Earnings yield (52.63%) (143.53%) (32.88%)
Free cash flow yield (39.71%) (42.21%) (23.13%)

Profitability

Metric CMPX CUE Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (262.03%) 0.00%
Net margin 0.00% (435.83%) 0.00%
Free cash flow margin 0.00% (133.13%) 0.00%
Return on equity (56.66%) (1,603.48%) (51.96%)
Return on assets (47.87%) (459.60%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CMPX CUE Biotechnology median
Revenue growth (TTM) — 354.37% 6.76%
EPS growth (last fiscal year) (16.67%) 61.11% 29.88%
Revenue growth, 5-year CAGR — 54.16% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMPX CUE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.22 1.25 4.97
Net debt to EBITDA 2.86 1.10 1.01

Dividend

Metric CMPX CUE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CMPX CUE Biotechnology median
Market cap 136.65m 136.06m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack